Improving predictions in colon cancer
Part of Cancer, Digestive system clinical trials.
This study is looking at ways to better predict how early-stage colon cancer will respond to standard treatment. It is focused on patients who will have surgery to remove the tumor and have not yet had any other cancer treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You have been newly diagnosed with colon cancer that has not spread to other parts of the body.
- Surgery to remove the tumor is planned and you are healthy enough for it.
- You are able to carry out daily activities with little or no help (ECOG score 0–3).
- You have not received chemotherapy, radiation, or other cancer treatment for this colon cancer before.
- You do not have another serious uncontrolled illness that could interfere with the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether giving additional (adjuvant) chemotherapy based on a special blood test—circulating tumor DNA (ctDNA)—can lower the risk of colon cancer coming back. It targets people with stage II–III colon cancer whose blood test is positive for minimal residual disease (MRD) after completing standard chemo.
This trial tests whether a blood test that looks at cancer DNA can help decide whether you need “adjuvant” (extra) chemotherapy after colon cancer surgery. It may help some patients avoid unnecessary chemotherapy while still keeping the cancer from coming back.
This study measures “minimal residual disease,” meaning tiny amounts of cancer that may remain after surgery, using blood samples. It may help doctors better detect who is at higher risk of cancer coming back and guide follow-up care.
This study is looking for people newly diagnosed with colorectal cancer or advanced adenoma to help find better ways to detect the disease early using advanced lab tests on blood samples.
This trial tests a new blood test to screen for colorectal cancer in people at average risk. You would give a blood sample before your scheduled colonoscopy, and the results will be compared to the colonoscopy findings.
This study tests whether a simple blood test can track how well your colorectal cancer is responding to first-line chemotherapy. By monitoring cancer markers in your blood, doctors may be able to detect treatment changes earlier than traditional imaging.
Hear when a new Colon Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.